No Data
No Data
H.C. Wainwright Maintains Gritstone Bio(GRTS.US) With Buy Rating, Maintains Target Price $4
Gritstone Bio to Host Virtual KOL Event to Discuss Unmet Need and Potential Role of Its Personalized Cancer Vaccine, GRANITE, in Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
Forecasting The Future: 4 Analyst Projections For Gritstone Bio
Express News | JMP Securities Reiterates Market Outperform on Gritstone Bio, Maintains $5 Price Target
JMP Securities Maintains Gritstone Bio(GRTS.US) With Buy Rating, Maintains Target Price $5
Express News | Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
No Data